IP Library › Assignment 025731/0104
Patent Assignment
Reel/Frame 025731/0104

Merger

Recorded: 2011-02-02 Pages: 9
Assignor
THROMB-X N.V.
Executed: 2007-07-19
Assignee
THROMBOGENICS N.V.
HERESTRAAT 49, LEUVEN, B-3000, BELGIUM
Covered Property (1)
Anti-Angiogenic Therapy
Patent: 8,758,748 →
Application: 12/973,155 →
Publication: US 2011/0123525
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 1, 2011
From: CARMELIET, PETER
To: VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW
Reel/Frame 025728/0388 →
Assignment of Assignor's Interest Feb 2, 2011
From: COLLEN, DESIRE
To: LIFE SCIENCES RESEARCH PARTNERS VZW
Reel/Frame 025730/0923 →
Assignment of Assignor's Interest Feb 2, 2011
From: STASSEN, JEAN-MARIE
To: THROMB-X N.V.
Reel/Frame 025730/0984 →
Change of Name Feb 13, 2019
From: THROMBOGENICS N.V.
To: OXURION NV
Reel/Frame 049255/0733 →